These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 11267194

  • 21. Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy.
    Zucker K, Rosen A, Tsaroucha A, de Faria L, Roth D, Ciancio G, Esquenazi V, Burke G, Tzakis A, Miller J.
    Transplant Proc; 1997; 29(1-2):334-6. PubMed ID: 9123027
    [No Abstract] [Full Text] [Related]

  • 22. Improved immunosuppression with combination tacrolimus (FK506) and mycophenolic acid in orthotopic liver transplantation.
    Cai TH, Esterl RM, Nichols L, Cigarroa F, Speeg KV, Halff GA.
    Transplant Proc; 1998 Jun; 30(4):1413-4. PubMed ID: 9636572
    [No Abstract] [Full Text] [Related]

  • 23. Mycophenolate mofetil/prednisolone/single-shot ATG with tacrolimus or cyclosporine in pancreas/kidney transplantation: first results of an ongoing prospective randomized trial.
    Schulz T, Konzack J, Büsing M.
    Transplant Proc; 1999 Jun; 31(1-2):591-2. PubMed ID: 10083251
    [No Abstract] [Full Text] [Related]

  • 24. Tolerability of mycophenolate mofetil in organ transplant recipients.
    Schweizer RT, Meisterling LD.
    Transplant Proc; 2001 May; 33(3):2309. PubMed ID: 11377540
    [No Abstract] [Full Text] [Related]

  • 25. Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations.
    Jain A, Kashyap R, Kramer D, Dodson F, Hamad I, Starzl TE, Fung JJ.
    Transplant Proc; 2001 May; 33(1-2):1342-4. PubMed ID: 11267319
    [No Abstract] [Full Text] [Related]

  • 26. Comparison of the safety and efficacy of mycophenolate mofetil, prednisolone and cyclosporine and conventional cyclosporine and prednisolone in kidney transplantation.
    Kim HC, Park SB, Kim HT, Cho WH, Park CH.
    Transplant Proc; 2000 Nov; 32(7):1751-2. PubMed ID: 11119919
    [No Abstract] [Full Text] [Related]

  • 27. Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus.
    Herrero JI, Quiroga J, Sangro B, Pardo F, Rotellar F, Cienfuegos JA, Prieto J.
    Transplant Proc; 2003 Aug; 35(5):1877-9. PubMed ID: 12962832
    [Abstract] [Full Text] [Related]

  • 28. Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients.
    Roth D, Colona J, Burke GW, Ciancio G, Esquenazi V, Miller J.
    Transplantation; 1998 Jan 27; 65(2):248-52. PubMed ID: 9458023
    [Abstract] [Full Text] [Related]

  • 29. Mycophenolate mofetil-based immunosuppressive therapy: induction, maintenance, and conversion protocols in renal transplantation.
    Land W.
    Transplant Proc; 1999 Dec 27; 31(8A):27S-32S. PubMed ID: 10616558
    [No Abstract] [Full Text] [Related]

  • 30. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients.
    Teebken OE, Strüber M, Harringer W, Pichlmaier MA, Haverich A.
    Transplant Proc; 2002 Jun 27; 34(4):1265-8. PubMed ID: 12072335
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus.
    Daly I, Jain A, Reyes J, Fung J.
    Transplant Proc; 2002 Aug 27; 34(5):1503. PubMed ID: 12176458
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Role of immunosuppressive treatments based on mycophenolate mofetil in posttransplantation renal surgical complications.
    Herrero JC, Andrés A, Leiva O, Diaz R, Polo G, Aguirre F, Villacampa F, Rodicio JL, Gonzalez E, Morales JM, Praga M.
    Transplant Proc; 2002 Feb 27; 34(1):96. PubMed ID: 11959201
    [No Abstract] [Full Text] [Related]

  • 36. A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C.
    Rayhill SC, Barbeito R, Katz D, Voigt M, Labrecque D, Kirby P, Miller R, Stolpen A, Wu Y, Schmidt W.
    Transplant Proc; 2006 Dec 27; 38(10):3625-8. PubMed ID: 17175350
    [Abstract] [Full Text] [Related]

  • 37. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
    Guethoff S, Meiser BM, Groetzner J, Eifert S, Grinninger C, Ueberfuhr P, Reichart B, Hagl C, Kaczmarek I.
    Transplantation; 2013 Feb 27; 95(4):629-34. PubMed ID: 23423270
    [Abstract] [Full Text] [Related]

  • 38. RS-61443/cyclosporine combination therapy prolongs canine liver allograft survival.
    Bechstein WO, Schilling M, Steele DM, Hullett DA, Sollinger HW.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 1):702-3. PubMed ID: 8438445
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.